BackErasca Overview
Erasca Inc

Erasca Target Price

Analysts' average 12-month price target for Erasca is $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.25

Average Target Price

$20.6745% upside

6 analysts in the last 4 months

High: $24 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13GuggenheimMichael Schmidt$2147.4% upsideOpen
2026-08-12H.C. Wainwright$2254.4% upsideOpen
2026-07-20Morgan Stanley$2147.4% upsideOpen
2026-07-14Jefferies$2468.4% upsideOpen
2026-07-14HSBC$2040.4% upsideOpen
2026-06-04Wolfe Research$1612.3% upsideOpen
2026-05-12Mizuho Securities$2682.5% upsideOpen
2026-04-27Stifel Nicolaus$30110.5% upsideOpen
2026-03-10Stifel NicolausLaura Prendergast$2040.4% upsideOpen
2026-01-27Guggenheim$1215.8% downsideOpen
2026-01-26Morgan StanleySean Laaman$1029.8% downsideOpen
2026-01-16Piper Sandler$1122.8% downsideOpen
2026-01-12Stifel NicolausLaura Prendergast$1029.8% downsideOpen
2026-01-08Morgan Stanley$471.9% downsideOpen
2026-01-07Piper Sandler$564.9% downsideOpen
2025-12-09Mizuho Securities$564.9% downsideOpen
2025-11-06Stifel Nicolaus$657.9% downsideOpen
2025-10-15Stifel NicolausLaura Prendergast$471.9% downsideOpen
2025-05-14GuggenheimMichael Schmidt$378.9% downsideOpen
2025-03-26Raymond JamesLaura Prendergast$564.9% downsideOpen
2024-11-18JefferiesMaury Raycroft$657.9% downsideOpen
2024-04-01Goldman SachsChris Shibutani$750.9% downsideOpen

Erasca (ERAS) FAQ

The latest target price for ERAS is $21. Investors often review this figure alongside Erasca's historical trend and sector peers before judging valuation or financial health.

Erasca trades near $14.25 while the consensus target sits at $21 (45.0% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ERAS's target price ($21), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Erasca's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.